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Improved cervical cancer screening in the United States has greatly reduced the 
incidence of cervical cancer and has led to a reduction in associated mortality associated 
with it through introduction of papanicolaou (Pap) testing in the middle 20
th
 century 
(Siegel, Naishadham, & Jemal, 2012). Since the introduction of cervical cancer 
screening, more recent research has shown a correlation between the human papilloma 
virus (HPV) and virtually all cervical cancers, specifically high risk types 16 and 18. 
However, according to the National Cancer Institute (NCI), “Most high risk HPV 
infections occur without any symptoms, and may cause cytological abnormalities or 
abnormal cell changes, but go away on their own within 1 to 2 years” (NCI, 2012, para. 
2). It is now understood that persistent infection with these high risk types of HPV is 
necessary for the development of cervical cancers and the precursors, cervical 
intraepithelial neoplasia grade 3 (CIN3), evidenced by epidemiologic case studies that 
show nearly 100% of cervical cancers test positive for HPV (Walboomers, et al, 1999). 
Due to this direct correlation, several organizations including the American Cancer 
Society (ACS), American Society for Colposcopy and Cervical Pathology (ASCCP), the 
American Society for Clinical Pathology (ASCP), the American College of Obstetricians 
and Gynecologists (ACOG), and the United States Preventative Task Force (USPTF), 
have recommended new guidelines for cervical cancer screening including utilizing Pap 
and HPV testing together dependent on age, pregnancy status, and previous cytology 




Problem Identification and Evidence 
Despite these recommendations, there are gaps nationwide in implementation of 
these screening guidelines. Although the recommendation to begin cervical cancer 
screening at age 21 was published by American Congress of Obstetricians and 
Gynecologists (ACOG) in 2009, a study  57% of adolescents age 18-21 were still 
receiving Pap testing as of 2011 (Hirth, Tan, Wilkinson, & Berenson, 2012). In addition, 
recommendations to discontinue Pap testing for women over age 65 who are not at high 
risk, or women who have undergone a total hysterectomy and have no history of cervical 
cancer have been well established since 2003. It is reported that 58% of women over the 
age of 65 have had a Pap test in the past 3 years, and 34% of women with a hysterectomy 
report a Pap test within the past 1 year (Kepka, Breen, King, Bernard, & Saraiya, 2014). 
This overuse of screening extends to increased frequency as well; many women continue 
to have annual Pap testing regardless of negative HPV status. This could be in part 
because according to one study, 31% of providers are still recommending annual testing 
to their patients (Meissner, Tiro, Haggstrom, & Coughlin, 2010). Over screening can 
result in an increase in abnormal results, leading to rising healthcare costs, additional 
office visits, and psychological stress for the patient with annual exams or incorrect 
procedures that yield little useful information or decrease in morbidity (Moyer, 2012). 
According to USPTF, “treatment of lesions that would otherwise resolve on their own is 
harmful because it can lead to procedures with unwanted side effects, including the 
potential for cervical incompetence and preterm labor” (Moyer, 2012, p. 884). Although 
consensus guidelines and algorithms detailing screening guidelines (Saslow et al., 2012) 
and management and follow up recommendations for all age groups, pregnancy status, 
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and cytology result were published by the ASCCP (Masaad, et al., 2012), providers are 
still performing unnecessary colposcopies, biopsies, and repeat Pap tests prior to 
recommended follow up. A brief summary of these recommendations is presented in 
Table 1. (Saslow et al., 2012, p. 149). 
 
This evidence based project will target the management of these abnormal results to 
reduce unnecessary procedures in a Family Practice Clinic at a Military Treatment 
Facility (MTF). 
In order to determine the extent of the problem in the setting, data will be 
gathered to assess unnecessary referrals for colposcopies when compared to 2012 
ASCCP guideline recommendations. In the Family Practice setting at this MTF, patients 
are referred to a colposcopy clinic for management by a group of residents and staff 
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physicians. Patient appointments are screened by a nurse and the staff physician 
overseeing the colposcopy clinic for appropriateness of referral. If the referral falls 
outside of the guidelines, the consult is then either returned to the referring provider, or 
scheduled based on provider discretion. The process can create confusion and anxiety for 
the patients, as they are told of their diagnosis and need for additional testing, then called 
back to be told to follow up in a given period of time for repeat cotesting based on current 
guidelines. This information would be gathered by collecting data for a 3-month period, 
screening all patients referred to the colposcopy clinic by comparing their cytology 
results and HPV status against 2012 ASCCP guidelines. A percentage will be calculated 
comparing patients within these guidelines to patients falling outside recommendations. 
Some diagnoses have repeat cotesting as preferred management, but allow colposcopy as 
an acceptable management option. These cases will be recorded as adhering to the 
guideline.  
The second component of successful implementation depends on the provider’s 
knowledge and comfort level with the guidelines. This would also be evaluated prior to 
implementation utilizing a survey (Appendix A) by the Association of Reproductive 
Health Professionals (ARHP), Cervical Cancer Screening Guidelines, monitoring 
providers’ responses in relation to frequency of screening, co-testing with HPV, and 
modified to include management of abnormal cytology results (ARHP, 2013a). The 
survey would also identify any barriers to utilization of the guidelines in the setting in 
order to target the educational intervention. A paper and pencil test would be 
administered to all providers within the Family Practice Clinic at the MTF, which 
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provides a baseline for gaps in understanding and a focus for the provider educational 
session. 
Program Context 
With any evidence-based research, there is typically a delay in implementation in 
the clinical setting. This is true with provider knowledge and use of the 2012 ASCCP 
guidelines for cervical cancer screening and management of abnormal cytology in a 
variety of settings nationwide. In 2013, the ARHP convened a consensus meeting with 
leading experts in cervical cancer prevention to identify practice gaps and barriers to 
implementation of these guidelines. The consensus meeting key points included the “need 
for clinical training opportunities about the new guidelines for HPV and cervical cancer 
screening and management” and that “significant gaps in knowledge exist around the 
areas of timing of Pap testing, cotesting with HPV, follow up testing, and concerns over 
persistence of HPV” (ARHP, 2013b, p. 2).  
Another contributing factor to the lack of adherence to the guidelines is the fact 
that they have changed multiple times over the last decade, and various professional 
organizations have adopted the recommendations at different points in time. Additionally, 
the algorithms for management of abnormal cytology are complex, with 19 pages of 
decision trees containing multiple options for management. Providers are hesitant to 
adopt the decreased screening intervals because many women use the annual Pap 
screening as their primary reason for accessing medical care; if they are only required to 
have it every three to five years, will they still come in for other routine screenings? 
(ARHP, 2013b & Meissner, 2010) This may extend to less aggressive management of 
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abnormal cytology. If it is not taken care of at the time of service, will patients return in 
one to three years for repeat testing? 
While these factors are issues across the nation in various clinical settings, 
specific sites have their own unique concerns in relation to implementation of new 
guidelines. In this project setting, the organization is a military treatment facility, which 
may affect project implementation both positively and negatively. Cost containment and 
reduction of unnecessary or outdated procedures is typically of great concern to the chain 
of command, especially with the political climate and budget scrutiny within the 
Department of Defense (DoD).  Stakeholders were presented with a cost analysis of the 
proposed intervention versus the cost savings with the number of procedures that could 
be eliminated, in order to generate command level support. However, this facility is a 
teaching facility, and providers are often only working in the particular setting for two to 
three years. This rapid turnover of clinicians as well as leadership leads to additional 
difficulty with proposed changes and maintenance. Approval for changes often takes 
several levels of permission within the command and can be a lengthy process. 
Possible barriers to implementation included both patient and provider factors, in 
addition to some of the concerns specific to the site as mentioned. Because patients are 
been used to annual Pap testing, some may be resistant to decreased frequency. In a 
survey by Sirovich, Woloshin, and Schwartz (2005), 75% preferred annual Pap 
screening, although only 43% had heard recommendations for less frequent intervals. 
When given the recommendations, over half of the women felt the changes were based 
on cost, and 69% of these would still pursue annual testing despite advisement from their 
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provider. This resistance could be defused by providing consistent, repeated education of 
patients by providers and handouts emphasizing main points. These handouts could also 
neutralize concerns by the providers with time constraints. Most delays in 
implementation of guidelines are not due to resistance, but practices being overstretched 
(ARHPb, 2013). A handout at check-in for any well woman exam would decrease time 
spent counseling patients. Providing education and evidence behind guideline changes 
may also assist providers with buy-in for themselves and talking points to discuss with 
their patients, reducing opposition to any proposed solutions. Provider time schedules 
may also create challenges for any educational sessions, as it could take time away from 
patient care. Offering educational breakfast prior to clinic hours or a lunch and learn 
opportunity provide incentive and work around scheduling conflicts. Other valid 
concerns and barriers to implementation include the training of new residents in a 
teaching facility. Changes to ASCCP guidelines in 2001 and 2006 have already reduced 
colposcopies by 45%, resulting in a difficulty producing competent providers able to 
perform colposcopies in the family practice setting. Decreases also affect maintenance of 
skills for providers as well, as it is recommended that at least 10 colposcopies a month be 
performed to sustain proficiency (Keehbauch, Green, Lugo, & Pepe, 2012). The ASCCP 
guidelines often recommend a preferred treatment with repeat co-testing at one year, but 
identify colposcopy as an acceptable management option for some cytology results. For 
this project, offering the patient the option, and not targeting reduction of these patient 




Evidence-based Practice Change Framework Model 
In order to implement change using evidence based practice, a well developed 
model framework can keep the project focused and increase chances of success. An 
effective framework to guide this project can be found in the Catalyst Model by Brown 
and Ecoff (2007), also referred to as the Evidence Based Practice Institute Model. This 
framework leads the clinician through several steps in order to bring evidence to practice. 
The framework begins with a catalyst, a problem or concern that is identified within an 
organization. The clinician then moves through the various steps, including assessing 
why the problem is important; asking, which develops a PICO question; acquiring, or 
searching the literature for evidence; appraising the evidence and determining if there is 
enough to support a practice change; applying the data by outlining the practice to be 
changed, identifying desired outcomes, and implementing change into practice; analyzing 
results pre and post change and whether there were any unintended consequences; and 
finally, advancing and adopting, in which the clinician shares results and adopts the 
practice organization wide (Brown and Ecoff, 2007). It is important to be thorough and 
organized prior to initiating the project, and this framework assisted to ensure all 
important components were addressed and prepared prior to implementation. 
Project Plan Process 
According to literature, evidence based solutions to implement guidelines and 
reduce unnecessary procedures include utilization of electronic medical record (EMR) 
prompting and decision tools (Broach, et al., 2013, White & Kenton, 2013), peer review 
or audit and feedback, (Sabatino et al., 2008), and provider in-services and education 
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(Lozman, Belcher, & Sloand, 2011). When evaluating which solution would best fit this 
practice setting, several factors were considered, including cost, availability of resources, 
feasibility, and acceptability of each option. Ideally, the proposed solution should have 
the strongest evidence base, and apply to a setting similar to an MTF Family Practice 
Clinic. With the EMR option, this would have been the most involved, as it would require 
an existing template within the specific computer interface, or the creation of a new one. 
In a military health system, the computer interface is utilized across DoD, and this may 
not be accomplished at a command level. This option was one of the most costly, and 
dependent on outside resources.  
A peer review or audit and feedback consists of evaluating performance in 
screening and management practices providing information to providers about their 
appropriate utilization of the guidelines. This may be performed after an educational 
component, and then accomplished with chart reviews targeted at abnormal Pap results. 
This would be inexpensive, require collaboration with Pathology Department Head or 
command computer super users to pull cytology and lab data, but no additional resources 
would be required. Data collection and notification could have been performed by the 
project implementer. Acceptability to providers may have been limited, however, as it 
could be perceived as punitive or interfering with provider discretion. Provider education 
could be accomplished during a 30-45 minute in-service targeting the knowledge gaps 
identified from a baseline survey. Lozman et al. (2011) recommended that educational 
sessions followed by a discussion period can also improve adherence to guidelines. This 
intervention was selected, as it was cost effective, and it would be delivered by the 
project implementer and a provider champion. This required no additional authorization, 
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utilized current resources available through professional organizations, and is typically 
well accepted in this setting.  
When evaluating the evidence to support provider education, there are multiple 
large systematic reviews and meta-analysis that address implementing guidelines into a 
practice setting.  Of the three strongest articles, two were meta-reviews that included 12 
and 41 systematic reviews respectively (Francke, Smit, de Veer, & Mistiaen, 2008, 
Grimshaw, et al., 2001) and one systematic review included 33 randomized controlled 
trials (Chaillet et al., 2006). These articles all concluded that a multifaceted approach to 
implementation was most successful versus single interventions such as provider 
education alone. Additionally, Grimshaw et al. (2001) concluded that “multifaceted 
interventions based on assessment of potential barriers to change are more likely to be 
effective” (p. II-26). Francke et al. (2008) discussed other considerations for successful 
implementation including complexity of the guideline, stating “when a guideline can be 
relatively easily understood and tried out, the chance is greater the guideline will be 
used”   (p. 7), and recommended targeted interventions in which providers “are directly 
and actively involved… combinations of (web-based, written, or face-to-face) practical 
recommendations, educational material, and educational meetings” (p. 8). Like 
Grimshaw et al., the study by Chiallet et al., (2006) stressed the importance of identifying 
barriers and adapting the intervention, resulting in significantly higher success rates 
compared to other interventions. This study also cited reminder systems as one effective 
component of the multifaceted approach. These are defined as “manual or computerized 
decision making systems…developed from clinical practice guidelines and pre-
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intervention study of barriers to change, an easy-to-use model” (Chiallet et al., 2006, p. 
1241).  
According to the Oxford Centre for Evidence-based Medicine Levels of 
Evidence, a systematic review of randomized controlled trials is considered level 1a 
evidence, or the highest quality and strength (Phillips et al., 2009). Although there is 
some heterogeneity in the results, it does not affect the aspects and interventions 
evaluated for this project. This means there is a strong evidence base to support these 
interventions. Because of the complexity of the algorithm, and the recommendations in 
the systematic reviews, a two part approach to implementation was planned; a provider 
education component in the form of a lunch and learn with a presentation and discussion 
portion, and selection of user friendly tools to assist providers with the application of the 
2012 ASCCP guidelines. Tools selected include a mobile app developed by the ASCCP, 
a free web based application, a one page simplified chart based on ASCCP guidelines, 
and a pocket sized booklet of the ASCCP algorithms (Appendix B). The educational 
session was developed using multiple evidence based resources including ARHP’s 
Applying Cervical Cancer Screening Guidelines to Clinical Practice (2014) and 
Managing HPV: A New Era in Patient Care (2013c), as well as Updated ASCCP 
Consensus Guidelines for Managing Abnormal Cervical Cancer Screening Tests and 
Cancer Precursors (Gold, 2014 & Lawson, 2014) and HPV Primary Screening in the 
United States (Mayeaux, 2014). Based on the results of the pre-intervention survey, 
knowledge gaps and barriers to implementation would be identified and educational 
presentations tailored to address these areas specifically. The 30 minute educational 
session is then followed by a 10-15 minute discussion to allow questions and response. 
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Providers would be trained on the user friendly tools for application of 2012 ASCCP 
guidelines, and any written information related to the tools distributed at the in-service. 
Case studies and examples to apply the tool to various patient scenarios are presented as 
well. 
Using the Catalyst Model, an important component of evidence based practice 
implementation includes developing a PICO question to focus on a specific patient 
population, intervention, comparison, and outcomes. Based on the literature to support 
the selected interventions, the PICO statement for this project is: 
In women ages 21 to 65 in a military treatment facility, does implementation of 
2012 ASCCP guidelines through provider education and utilization of user 
friendly tools decrease the number of unnecessary referrals for colposcopy? 
Program Objectives 
Successful implementation of the project would result in meeting several 
objectives focused on short term and long term impact to the patient, providers, and 
organization as a whole. The initial outcome objective was focused on improving the 
provider knowledge of the 2012 ASCCP guidelines for management of abnormal 
cytology and increased utilization of the guidelines in the setting. The increase in 
provider utilization should then result in a secondary outcome, a decrease of unnecessary 
referrals to the colposcopy clinic. The goal was to decrease unnecessary referrals by 25%. 
The focus of this objective will depend on pre-intervention data collection, the number of 
unnecessary referrals falling outside of recommendations according to 2012 ASCCP 
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guidelines. One effect on the organization if these objectives are met would be a decrease 
in cost to the command. Furthermore, if providers are more knowledgeable and refer less 
procedures unnecessarily, this would result in a time savings to the providers, both 
deciding management for abnormal cytology results, and for the colposcopy clinic 
screening and returning inappropriate referrals. This allows providers to spend more time 
on patient care rather than administrative tasks. Also, because patients are receiving clear 
recommendations, it would result in a decrease in patient anxiety, an increase in patient 
confidence in their provider and increased patient satisfaction. These are long term 
outcomes that will not be measured for the purposes of this project, but ultimately make a 
positive impact. 
Evaluation Results 
Despite initial support from site stakeholders, departmental leadership, and 
providers in the Family Practice Clinic, data collection and delivery of educational 
session was ultimately not implemented due to multiple project barriers. Although the 
project was reviewed and approved by the Clinical Investigation Department in August of 
2014 as a Process Improvement and Quality Assurance (PI/QA) project, changes to the  
Institutional Review Board (IRB) process during project implementation created delays 
in delivery of intervention and data collection. Shortly after approval to proceed as a 
PI/QA project requiring only a letter of departmental support and chain of command 
notification, the Clinical Investigative Head position at the site was eliminated. When 
scheduling of educational session and administration of provider survey was to be 
arranged in December 2014, a new, formalized approval process for PI/QA projects was 
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created. In the same timeframe, the clinical mentor was sent on a temporary duty 
assignment for military training for a six week period beginning December 2014. In 
addition, staff turnover occurred in two key leadership positions involved as project 
stakeholders during fall of 2014. 
At a command level, there were also several barriers that halted project 
implementation including the importance of the site for colposcopy training of residents 
and for maintenance of colposcopy skills for family practice physicians. Stakeholders in 
higher leadership positions were concerned about maintenance of these educational 
programs for new staff if the number of colposcopies were reduced. Higher levels of 
leadership also perceived a mismatch between project goals and the current Healthcare 
Effectiveness Data and Information Set (HEDIS) measure of all eligible patients having a 
Pap within last 3 years. Although cost containment is a typically a goal of Military 
Medicine, this particular project ultimately was not a priority to the command due to 
competing resource allocation and higher priority educational needs of the organization.  
Conclusion 
The evidence based research and literature review presented in this project was strong 
enough to support implementation of the proposed change in this setting, and in a facility 
such as a Family Practice Clinic in a Military Treatment Facility, a cost savings based on 
evidence based practice changes would be a great benefit to the patients, providers, and 
the organization as a whole. The cost of this project would be minimal, taking into 
consideration the implementers time, which is donated as a student, cost of supplies 
including paper for surveys, laminated handouts, and booklets for provider participants. 
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The cost benefit to the command from program implementation would include the cost 
savings of repeat visits including provider time, Pap testing or colposcopy cost which 
averages $500-$1000 depending on the number of biopsies performed,  times the number 
of patients per year with unnecessary referrals to the colposcopy clinic. Additional cost 
savings to take into consideration include collection supplies (speculum, swabs, transport 
media, linen, exam table paper, chux); lab costs (personnel and lab testing supplies); 
provider time not only for the visit, but also time spent looking up recommendations for 
management and calling patient with results; cost of assistive personnel to get vitals, 
standby for exam, process specimens, order labs, transport specimens, and clean the 
room. 
Although the project appears to be cost effective, when beginning Evidence Based 
Practice project implementation, consideration for benchmarking improvement goals, 
mission and vision of the organization is of equal or greater importance to the success of 
the project. Additionally, one should anticipate more levels of approval, larger number of 
stakeholders in military health systems. Other obstacles include frequent turnover of 
leadership and key personnel creating additional challenges to organizational change in 
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Provider Survey of Cervical Cancer Screening and Management 
Thank you for your time completing this survey. All surveys will be anonymous. 
1. What is your professional category? 
a. Certified Nurse Midwife  
b. Nurse Practitioner 




g. Student (NP, PA, Medical Student) 
h. Other (Please Specify):__________________________________________ 
2.  How many years have you been practicing as a provider? 
a. 1-2 years 
b. 2-5 years 
c. 5-10 years 
d. 10 or more years 
3.  How would you describe the setting of your primary clinical practice? 
a. Primary Care Clinic 
b. OB/GYN 
c. Internal Medicine 
d. Other (Please Specify):__________________________________________ 
4. Do you perform PAP testing and/or colposcopies? 
a. Yes, I perform both PAP tests and colposcopies 
b. I perform PAP testing only 
c. No, I am not able to perform PAP testing or colposcopies  
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5.  How would you describe your level of proficiency regarding the latest cervical 
cancer screening guidelines including HPV testing? 
a. Expert (recognized authority)  
b. Advanced 
c. Intermediate (practical application) 
d. Novice 
e. Fundamental Awareness (basic knowledge) 
6. How would you describe your level of proficiency regarding guidelines for 
management of abnormal cytology? 
a. Expert (recognized authority) 
b. Advanced 
c. Intermediate (practical application) 
d. Novice 
e. Fundamental Awareness (basic knowledge) 
7. What do you believe are the primary barriers to integration of the guidelines for 
cervical cancer screening and management of abnormal cytology (circle ALL that 
apply)? 
a. Lack of knowledge or awareness about new guidelines 
b. Ensuring patients' continuity of care 
c. Patient resistance (i.e. desire for annual Pap test) 
d. Provider time used to explain new guidelines to patients 
e. Colleagues' resistance to change 
f. Administrative barriers 
g. Frequently changing guidelines 
h. Guidelines very complex and difficult to apply to practice 







8.  How are you using HPV testing in screening? 
a. Substitute for regular cervical cytology screening 
b. Follow-up to ASCUS or abnormal tests only 
c.    Cotesting all women age 21 and older 
d.   Follow-up to ASCUS in women 21 to 29 and cotesting for women 30 and 
older 
 e.   I'm not using HPV testing 
 f.ffOther (please specify):__________________________________________ 
____________________________________________________________ 
9.  15. Have you ordered an HPV 16/18 genotyping test in the past 6 months? (i.e. a 




10.  If no, why haven't you ordered an HPV 16/18 genotyping test in the past 6 months? 
(check ALL that apply) 
a. I was unaware a genotyping test existed. 
b. The test is not available at the lab I use. 
c. I am not convinced of the medical or clinical value of the test. 
d. I am unclear on what I would do differently with the results of the test. 
e. Use of this test is not consistent with screening guidelines. 
f. Other (Please Specify):_______________________________________ 
_________________________________________________________ 
11. What resources do you currently use to determine management of an abnormal 
cytology result? 
a. UpToDate 
b. ASCCP Algorithms  
c. Mobile App 
d. Expert provider in my clinic 
e. Expert provider in another specialty clinic 
f. Same management as I have used in the past 
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g. Other (Please Specify):____________________________________________ 






13. Which one of the following statements about HPV testing for cervical cancer 
screening is not correct? 
a. It should be used instead of cytology for women under age 25 
b. It assesses future risk not just current disease 
c. Identifies cervical cancer precursors earlier 
d. HPV negative women have a lower risk of cervical cancer than cytology 
negative women 
14. Based on current consensus-based cervical cancer screening guidelines, which 
statement below is correct?  
a. Cervical cytology alone is not acceptable as a primary method of cervical 
cancer screening 
b. Primary HPV screening should begin at age 30 
c. Cotesting (HPV testing and cervical cytology) is preferred in women 25 years 
of age and older 
d. Cotesting (HPV testing and cervical cytology) is preferred in women 30 years 
of age and older 
e. Cotesting (HPV testing and cervical cytology) is preferred in women 35 years 






15. A 32 year-old patient arrives for a well woman exam at your clinic. Her last visit was 
5 years ago. She is currently sexually active with a new partner. You perform 
cotesting with cervical cytology and HPV testing, and her results show ASC-US with 
negative HPV. What is your management of this patient? 
a. Refer for colposcopy  
b. Repeat cotesting in 12 months 
c. Repeat cotesting in 3 years 
d. Repeat cotesting in 5 years 
e. Both a or b would be acceptable 
16. Another patient, a 44 year old woman in a mutually monogamous relationship for the 
past 20 years, arrives for her well woman exam. Her last visit was 3 years ago, with a 
negative cytology, but no previous HPV testing. You perform cotesting, and her 
results show negative cytology with a positive HPV. What is your management of 
this patient? 
a. Refer for colposcopy 
b. Repeat cotesting in 12 months 
c. Perform HPV genotyping 
d. Repeat cotesting in 3 years 
e. Both b or c would be acceptable 
17. Your last patient is a 22 year old woman presenting for her first well woman exam, 
she is not sexually active. You perform cytology alone, and her results show Low-
grade Squamous Intraepithelial Lesion (LSIL). What is your management of this 
patient? 
a. Refer to colposcopy 
b. Repeat cytology alone in 12 months 
c. Routine screening 
d. Perform reflex HPV testing 
e. Both b or d would be acceptable 
18. Which of the following information topics would be helpful to better understand 
cervical cancer screening and management of abnormal cytology guidelines (check 
best THREE choices)? 
a. Explanation of the natural history of HPV and the development of cervical 
cancer 
b. Understanding of the difference between transient and persistent infection 
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c. Data behind extended screening interval 
d. Real world data on loss of follow-up due to extended screening interval 
e. What should be included in the annual visit if it no longer focuses on the Pap 
test 
f. Case studies of patients with varying test results 
g. Ongoing follow up after colposcopies 
h. When to return to normal screening intervals after abnormal cytology or 
colposcopy 
i. Other (Please Specify):____________________________________________ 
_______________________________________________________________ 
19. Which of the following tools or educational activities would be helpful to you in 
applying guidelines for cervical cancer screening or management of abnormal 
cytology (check best THREE choices)? 
a. Patient education fact sheets  
b. Inclusion of cervical cancer screening measures and management guidelines 
in electronic medical record (EMR)  
c. Quality measures such as HEDIS that include HPV testing 
d. Web based tool for providers to apply the guidelines 
e. Smartphone apps 
f. Simplified algorithms 
g. CME Web-based educational sessions 

























User friendly tool to apply 2012 ASCCP Guidelines;  
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Purpose: The purpose of this evidence-based project is to decrease unnecessary 
procedures using provider education and user friendly tools to apply the 2012 American 
Society for Colposcopy and Cervical Pathology (ASCCP) Guidelines at a Military 
Treatment Facility Family Practice Clinic. 
Background: Currently, in the United States, despite clear cervical cancer screening 
guidelines, it is reported that 58% of women over the age of 65 have had a Pap test in the 
past 3 years and 34% of women with a hysterectomy report a Pap test within the past 1 
year. Additionally, 57% of adolescents age 18-21 were still receiving Pap testing as of 
2011. Women are continuing to have annual Pap testing regardless of negative HPV 
status, partly because 31% of providers are still recommending annual testing to their 
patients. This over screening can result in an increase in false positive results, leading to 
rising healthcare costs, additional office visits, and psychological stress to the patient 
with annual exams or incorrect procedures that yield little useful information or decrease 
in morbidity. Although consensus guidelines and algorithms detailing screening 
guidelines, management and follow up recommendations have been published by the 
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ASCCP, providers are still performing unnecessary colposcopies, biopsies, and repeat 
Pap tests prior to recommended follow up. 
Methods: This project will utilize the Catalyst Model by Brown & Ecoff, also referred to 
as the Evidence Based Practice Institute Model. According to this model, after identifying 
the catalyst and describing why the problem is important, we develop a PICO question, 
search the literature for evidence, and appraise the evidence to determine if there is 
enough to support a practice change. Problem assessment in the setting will be done by 
identifying unnecessary procedures by comparing management of abnormal PAP results 
over 3 month period to the 2012 ASCCP guideline recommendations. Next, provider’s 
knowledge and comfort level with guidelines will be assessed using a survey on the 
frequency of screening, use of co-testing with HPV, and management of abnormal 
cytology results. Once this data is obtained, the data will be applied by outlining the 
practice to be changed, identifying desired outcomes, and implementing change into 
practice through provider education. Educational sessions will be developed and 
conducted using multiple tools to help providers apply the algorithms for abnormal 
cytology algorithms including a web-based tool, mobile app, and simplified one-page 
algorithm. 
Outcomes Achieved: A second chart review will be conducted 3 months after the 
intervention in the same manner to identify the number of inappropriate management of 
Pap results according to the ASCCP guidelines. 
 Conclusions: If successful, implementation will increase provider comfort level and 
knowledge of the guidelines, which will in turn lead to decreased numbers of 
appointments and follow-up procedures, therefore a decrease in cost to the clinic.  It may 


















 Nationwide, women still being over screened
◦ 58% women >65 report Pap in past 3 years
◦ 34% of women with a hysterectomy  report Pap in last 1 
year
◦ 57% of adolescents age 18-21 have had Pap testing
◦ Women continuing to have annual Pap testing
◦ 31% of providers still recommending annual testing to their 
patients 
 Although consensus guidelines and algorithms 
for screening, management and follow up 
published, providers are still performing 
unnecessary colposcopies, biopsies, and repeat 




 3 different practice settings - frustration, 
confusion with algorithms
 Ultimately, chose Military Treatment Facility 
Family Practice Clinic
◦ Pt has Pap smear in FP 
◦ If abnormal refer to colposcopy clinic
◦ Colposcopy clinic 2 days a week




 Inefficiencies with referral process
◦ Providers not comfortable with algorithms-
spending additional time determining management
◦ Colposcopy clinic needing to spend time screening 
appropriateness of referrals
◦ Patient confusion, anxiety with plan of care
 Training for new residents, not referring 





 Improve provider usage of the 2012 ASCCP 
guidelines.
 Decrease of unnecessary colposcopy referrals
 Ultimately (unmeasured)
◦ Decrease cost
◦ Decrease patient anxiety due to less unnecessary 
procedures




 In women ages 21 to 65 in a military 
treatment facility, does implementation of 
2012 ASCCP guidelines through provider 
education and utilization of a user friendly 





 Multifaceted approach vs. single interventions such 
as provider education alone
 Targeted interventions actively involving providers
◦ Combinations of practical recommendations, educational 
material, and educational meetings
 Reminder systems
◦ Manual or computerized decision making systems
◦ Developed from clinical practice guidelines
◦ pre-intervention study of barriers to change
◦ Easy-to-use model





 Data to be collected as a two step process:
 Step 1-Over a 3 month period, assess the number of 
unnecessary referrals by comparing cytology and HPV 
results to management recommendations based on 
2012 ASCCP guidelines
 Step 2- Assess barriers to implementation, provider’s 
knowledge and comfort level of guidelines utilizing a 
survey  including frequency of screening, co-testing 
with HPV, and management of abnormal cytology 





• Obtain Site approval
• Collect Pre-Data x 3 months
• Select User Friendly Tools
• Report to stakeholders
Jan-May 14
• Develop survey and educational session 
• Administer provider survey 
• Deliver educational session 
Sept.- Dec 14
• Collect Post-data x 3 months
• Analyze results
• Report to stakeholders
Jan - Mar 15 
• Discuss project with stakeholders






 Loss of Clinical Investigative Head position and 
formal IRB and QA/PI approval 
◦ changing number of stakeholders
 Staff turnover/deployments
 Lack of project urgency/priority within chain of 
command
◦ Mismatch of HEDIS measure-Pap within 3 years, 
perception of mixed message-no measure to decrease 
unnecessary procedures
◦ Residents need colposcopies for training and 
sustainment





 Helpful if project aligns with benchmarking 
data for clinic
 Anticipate more levels of approval, larger 
number of stakeholders in Military health 
systems
 Reluctance for identification of deficiencies 
especially from outside sources-concern for 
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